作者
Tengiz Tsertsvadze, Amiran Gamkrelidze, Nikoloz Chkhartishvili, Akaki Abutidze, Lali Sharvadze, Vakhtang Kerashvili, Maia Butsashvili, David Metreveli, Lia Gvinjilia, Shaun Shadaker, Muazzam Nasrullah, Ekaterine Adamia, Stefan Zeuzem, Nezam Afdhal, Sanjeev Arora, Karla Thornton, Beth Skaggs, Tinatin Kuchuloria, Maia Lagvilava, David Sergeenko, Francisco Averhoff
发表日期
2020/8/22
期刊
Clinical Infectious Diseases
卷号
71
期号
5
页码范围
1263-1268
出版商
Oxford University Press
简介
Background
In April 2015, in collaboration with the US Centers for Disease Control and Prevention and Gilead Sciences, the country of Georgia embarked on the world’s first hepatitis C elimination program. We aimed to assess progress toward elimination targets 3 years after the start of the elimination program.
Methods
We constructed a hepatitis C virus (HCV) care cascade for adults in Georgia, based on the estimated 150 000 persons aged ≥18 years with active HCV infection. All patients who were screened or entered the treatment program during April 2015–March 2018 were included in the analysis. Data on the number of persons screened for HCV were extracted from the national HCV screening database. For the treatment component, we utilized data from the Georgia National HCV treatment program database. Available treatment options included sofosbuvir and …
学术搜索中的文章
T Tsertsvadze, A Gamkrelidze, N Chkhartishvili… - Clinical Infectious Diseases, 2020